The fields of pharmacology and pharmaceutical sciences converge to advance our understanding of how drugs interact with biological systems and how these agents can be engineered for optimal ...
Spinogenix received FDA authorization earlier this year for an Expanded Access Program, providing access to 200 ALS individuals ineligible for clinical trials in the United States. SPG302 has also ...
GlobalData on MSN
Dewpoint receives FDA orphan drug designation for DPTX3186
The ODD programme incentivises the development of medicines for conditions affecting fewer than 200,000 individuals in the US ...
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to DPTX3186, an investigational therapy being ...
Join us as experts discuss the future of cancer drug discovery, focusing on breakthroughs in genomics and targeted therapies.
In a recent study published in the American Society for Microbiology, researchers developed a novel rabbit infection model to investigate meropenem's resistance development potential and antibacterial ...
First orphan designation ever granted to a condensate-modulating therapeuticBuilds on recent IND opening for DPTX3186, a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback